LQA for Clinical Trial Report Documentation for a Pharmaceutical Company

How Peoplying Delivered Document-Level LQA for High-Stakes Clinical Trial Reporting Materials

In pharmaceutical translation, quality assurance must go beyond sentence-level correctness. Clinical trial reports contain highly sensitive scientific, regulatory, and medical information, and the final translated documents must be checked for accuracy, consistency, and usability in their full document context. In these cases, Linguistic Quality Assurance (LQA) plays a critical role in strengthening trust and reducing risk before submission or internal circulation.

This case study shows how Peoplying supported an anonymous pharmaceutical company by conducting document-level LQA for clinical trial report materials, helping the client validate translated content in context and improve consistency across highly regulated documentation.

Project Overview

The client required LQA support for translated clinical trial reporting documents. The review scope included:

• clinical trial report content,
• medical and scientific narrative sections,
• study-related documentation,
• tables, headings, and supporting explanatory text,
• terminology and phrasing used across the document set.

The client’s goals were to:

• validate the linguistic quality of translated clinical documentation,
• improve consistency of medical and regulatory terminology,
• reduce quality risk in high-stakes reporting materials,
• ensure the final documents were reliable for professional use.

Key Challenges

1) High-Risk Medical and Regulatory Content
Clinical trial documentation contains specialized content where precision is essential. Errors or inconsistencies can affect interpretation and confidence in the material.

2) Document-Level Context Matters
Many issues in clinical documents only become visible when the full report is reviewed as a complete document rather than as isolated segments.

3) Consistency Across Repeated Terminology and Sections
The same medical, procedural, and study-specific terms often appear repeatedly across report sections and needed to remain consistent throughout.

4) Formal Tone and Reporting Accuracy
The translated text needed to preserve a professional, medically appropriate tone suitable for regulated and expert-facing communication.

Peoplying’s Approach

1) Medical and Pharmaceutical LQA Reviewers
Peoplying assigned reviewers experienced in pharmaceutical and clinical documentation to conduct document-level LQA.

2) Full-Document Contextual Review
The review focused not only on segment-level accuracy, but also on the complete document context, including:

• consistency across repeated sections,
• alignment of terminology and phrasing,
• tone suitability for clinical reporting,
• coherence of document flow and structure.

3) Terminology and Reporting-Language Validation
Particular attention was paid to medical and study-related terminology, as well as reporting-style language used throughout the materials.

4) Structured LQA Feedback for Correction Cycles
Issues were documented in a clear format to support correction, internal validation, and improved final document quality.

Results

Peoplying delivered document-level LQA that improved the reliability of translated clinical reporting materials:

• stronger consistency across report sections and repeated terminology,
• improved confidence in the linguistic quality of clinical trial documentation,
• reduced risk of document-level inconsistency and phrasing issues,
• better readiness for professional and regulated communication use.

By combining pharmaceutical-domain expertise with document-context review, Peoplying helped the client strengthen translation quality in a highly sensitive documentation environment.

What This Shows

• Clinical trial documentation requires full-document LQA, not only segment-level review.
• Medical and regulatory materials benefit from strong terminology and consistency validation.
• LQA adds essential value in high-risk pharmaceutical communication.